i
Hidden Epidemic of Macrolide-resistant Pneumococci
-
Jun 2005
-
Source: Emerg Infect Dis. 11(6):802-807.
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Community-acquired respiratory tract infections (RTIs) account for a substantial proportion of outpatient antimicrobial drug prescriptions worldwide. Concern over the emergence of multidrug resistance in pneumococci has largely been focused on penicillin-resistant Streptococcus pneumoniae. Macrolide antimicrobial drugs have been widely used to empirically treat community-acquired RTIs because of their efficacy in treating both common and atypical respiratory pathogens, including S. pneumoniae. However, increased macrolide use has been associated with a global increase in pneumococcal resistance, which is leading to concern over the continued clinical efficacy of the macrolides to treat community-acquired RTIs. We provide an overview of macrolide-resistant S. pneumoniae and assess the impact of this resistance on the empiric treatment of community-acquired RTIs.
-
Subjects:
-
Source:
-
Document Type:
-
Volume:11
-
Issue:6
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: